Matthias Alder - Net Worth and Insider Trading

Matthias Alder Net Worth

The estimated net worth of Matthias Alder is at least $75,350 dollars as of 2024-05-11. Matthias Alder is the EVP, Bus. Dev.&Lic, G.C. &Sec. of Sucampo Pharmaceuticals Inc and owns about 3,449 shares of Sucampo Pharmaceuticals Inc (SCMP) stock worth over $62,082. Matthias Alder is also the CEO of Gain Therapeutics Inc and owns about 5,286 shares of Gain Therapeutics Inc (GANX) stock worth over $13,268. Details can be seen in Matthias Alder's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthias Alder has not made any transactions after 2023-12-21 and currently still holds the listed stock(s).

Transaction Summary of Matthias Alder

To

Matthias Alder Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthias Alder owns 1 companies in total, including Gain Therapeutics Inc (GANX) .

Click here to see the complete history of Matthias Alder’s form 4 insider trades.

Insider Ownership Summary of Matthias Alder

Ticker Comapny Transaction Date Type of Owner
GANX Gain Therapeutics Inc 2023-12-21 Chief Operating Officer

Matthias Alder Latest Holdings Summary

Matthias Alder currently owns a total of 2 stocks. Among these stocks, Matthias Alder owns 3,449 shares of Sucampo Pharmaceuticals Inc (SCMP) as of November 28, 2016, with a value of $62,082 and a weighting of 82.39%. Matthias Alder also owns 5,286 shares of Gain Therapeutics Inc (GANX) as of December 21, 2023, with a value of $13,268 and a weighting of 17.61%.

Latest Holdings of Matthias Alder

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SCMP Sucampo Pharmaceuticals Inc 2016-11-28 3,449 18.00 62,082
GANX Gain Therapeutics Inc 2023-12-21 5,286 2.51 13,268

Holding Weightings of Matthias Alder


Matthias Alder Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthias Alder has made a total of 0 transactions in Sucampo Pharmaceuticals Inc (SCMP) over the past 5 years. The most-recent trade in Sucampo Pharmaceuticals Inc is the sale of 150,000 shares on November 28, 2016, which brought Matthias Alder around $2 Million.

According to the SEC Form 4 filings, Matthias Alder has made a total of 2 transactions in Gain Therapeutics Inc (GANX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Gain Therapeutics Inc is the sale of 206 shares on December 21, 2023, which brought Matthias Alder around $507.

Insider Trading History of Matthias Alder

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthias Alder Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthias Alder Ownership Network

Ownership Network List of Matthias Alder

No Data

Ownership Network Relation of Matthias Alder


Matthias Alder Owned Company Details

What does Gain Therapeutics Inc do?

Who are the key executives at Gain Therapeutics Inc?

Matthias Alder is the Chief Operating Officer of Gain Therapeutics Inc. Other key executives at Gain Therapeutics Inc include Chief Financial Officer Charles Evan Ballantyne , Principal Accounting Officer Gianluca Fuggetta , and Chief Financial Officer Salvatore Calabrese .

Gain Therapeutics Inc (GANX) Insider Trades Summary

Over the past 18 months, Matthias Alder made 2 insider transaction in Gain Therapeutics Inc (GANX) with a net sale of 2,026. Other recent insider transactions involving Gain Therapeutics Inc (GANX) include a net purchase of 30,000 shares made by Jeffrey Scott Riley ,

In summary, during the past 3 months, insiders sold 0 shares of Gain Therapeutics Inc (GANX) in total and bought 30,000 shares, with a net purchase of 30,000 shares. During the past 18 months, 2,026 shares of Gain Therapeutics Inc (GANX) were sold and 30,000 shares were bought by its insiders, resulting in a net purchase of 27,974 shares.

Gain Therapeutics Inc (GANX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Gain Therapeutics Inc Insider Transactions

No Available Data

Matthias Alder Mailing Address

Above is the net worth, insider trading, and ownership report for Matthias Alder. You might contact Matthias Alder via mailing address: C/o Micromet, Inc., 6707 Democracy Blvd., Ste. 505, Bethesda Md 28017.

Discussions on Matthias Alder

No discussions yet.